Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

OPKO, Pfizer Enter Into Global Agreement for hGh

December 15, 2014 10:44 am | News | Comments

OPKO Health, Inc. and Pfizer Inc. announced that they have entered into a worldwide agreement for the development and commercialization of OPKO’s long-acting hGH-CTP for the treatment of growth hormone deficiency (GHD) in adults and children, as well as for the treatment of growth failure in children born small for gestational age (SGA) who fail to show catch-up growth by 2 years of age. Read more...

TOPICS:

Potential Hepatitis B Cure Enters Clinical Trial

December 15, 2014 8:52 am | News | Comments

A new treatment promoting the cure of chronic hepatitis B is now recruiting patients for clinical trials. Read more....                        

TOPICS:

Key Human Gene Modifies Immune Response to Flu Vaccine

December 12, 2014 11:24 am | News | Comments

How much protection the annual flu shot provides depends on how well the vaccine (which is designed based on a "best guess" for next season's flu strain) matches the actually circulating virus. However, it also depends on the strength of the immune response elicited by the vaccine. Read more...

TOPICS:
Advertisement

J&J Collaborates with Janssen,USAID to Expand Access to MDR-TB Compound

December 12, 2014 11:15 am | News | Comments

Johnson & Johnson today announced that its affiliate Janssen Therapeutics, Division of Janssen Products, LP (Janssen), has signed a Memorandum of Understanding (MOU) representing the intention of the Company along with the United States Agency for International Development (USAID) to step up the fight against the health threat of antibiotic-resistant bacteria. Read more...

TOPICS:

CA Battles Whooping Cough Epidemic

December 12, 2014 11:07 am | News | Comments

California officials are battling the worst whooping cough epidemic to hit the state in seven decades as a recent rebound in cases raises questions about the effectiveness of the pertussis vaccine. Read more...                    

TOPICS:

Taming Inflammatory Response in Kidney Dialysis

December 12, 2014 11:02 am | News | Comments

Over the past several years, lead author John Lambris, PhD, the Dr. Ralph and Sallie Weaver Professor of Research Medicine, Perelman School of Medicine at the University of  Pennsylvania, and his colleagues have developed small molecule versions of the drug compstatin, which inhibits a component of the complement immune response called C3. Read more...

TOPICS:

Hep C Ruled Out as Mental Impairment Cause in HIV

December 12, 2014 10:52 am | by Michael C. Purdy, Washington University | News | Comments

Advances in treatment for human immunodeficiency virus (HIV) have made it possible for people with HIV to survive much longer. As they age, however, many experience impaired thinking, memory loss, mood swings and other evidence of impaired mental function. Read more... 

TOPICS:

Understanding Intestinal Microbiota to Regain Balance in the Gut

December 12, 2014 10:42 am | by Natalie Duggan, Emory | News | Comments

When you take antibiotics, some of the beneficial germs can be wiped out, leaving you more vulnerable to diarrheal infections—infections, in some cases, that are antibiotic resistant and life-threatening. Read more...                                    

TOPICS:
Advertisement

TWi Biotechnology Receives FDA Protocols for Gout Drug

December 12, 2014 10:30 am | News | Comments

TWi Biotechnology Inc. has received US FDA and Taiwan FDA approval of a protocol for a Phase 2 clinical trial of gout drug. Read more...                     

TOPICS:

Merck Helps Africa Fight Parasitic Worm Disease

December 12, 2014 10:22 am | News | Comments

Merck announced that Ethiopia will receive around 13 million praziquantel tablets in 2015. Read more...                          

TOPICS:

Abbott Acquires Veropharm for $305M

December 12, 2014 9:56 am | News | Comments

Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer. Read more...                        

TOPICS:

Team Discovers Reasons for Malaria's Drug Resistance

December 12, 2014 9:38 am | by Nanyang Technological University | News | Comments

Scientists have discovered exactly how the malaria parasite is developing resistance towards the most important front-line drugs used to treat the disease. Read more...                

TOPICS:

Avian Flu Spreading in Southwest British Columbia

December 12, 2014 9:27 am | News | Comments

Avian influenza poses little danger to people as long as poultry meat is handled and cooked properly. Read more...                         

TOPICS:

Avian Flu Spreading in Southwest British Columbia

December 12, 2014 9:27 am | News | Comments

Avian influenza poses little danger to people as long as poultry meat is handled and cooked properly. Read more...                         

TOPICS:

Mali: Last Known Ebola Case Cured, Released

December 12, 2014 9:22 am | by Sarah Dilorenzo - Associated Press | News | Comments

The last Ebola patient being treated in Mali has survived the disease and been released. Read more...                           

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading